Tumor Necrosis Factor Alpha Induction of NF-κB Requires the Novel Coactivator SIMPL

REFERENCES

• Baldwin, A. S. 2001. The transcription factor NF-κB and human diseases. J. Clin. Investig. 107:3–6.
   PubMed Web of Science ®Google Scholar
• Chen, Z. J., Parent L., and Maniatis T.. 1996. Site-specific phosphorylation of IkBa by a novel ubiquitination-dependent protein kinase activity. Cell 84:853–862.
   PubMed Web of Science ®Google Scholar
• DiDonato, J. A., Hayakawa M., Rothwarf D. M., Zandi E., and Karin M.. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388:548–554.
   PubMed Web of Science ®Google Scholar
• Efthymiadis, A., Shao H., Hubner S., and Jans D. A.. 1997. Kinetic characterization of the human retinoblastoma protein bipartite nuclear localization sequence (NLS) in vivo and in vitro. J. Biol. Chem. 272:22134–22139.
   PubMedGoogle Scholar
• Fontes, M. R. M., The T., and Kobe B.. 2000. Structural basis of recognition of monopartite and bipartite nuclear localization sequences by mammalian importin-α. J. Mol. Biol. 297:1183–1194.
   PubMed Web of Science ®Google Scholar
• Hedin, K. E., Bell M. P., Kalli K. R., Huntoon C. J., Sharp B. M., and McKean D. J.. 1997. Delta-opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element. J. Immunol. 159:5431–5440.
   PubMedGoogle Scholar
• Hoffmann, A., Leung T. H., and Baltimore D.. 2003. Genetic analysis of NF-kB/Rel transcription factors defines functional specificities. EMBO J. 22:5530–5539.
   PubMed Web of Science ®Google Scholar
• Hu, Y., Baud V., Delhase M., Zhang P., Deerinck T., Ellisman M., Johnson R., and Karin M.. 1999. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase. Science 284:316–320.
   PubMed Web of Science ®Google Scholar
• Ito, C. Y., Kazantsev A. G., and Baldwin A. S.. 1994. Three NF-κB sites in the IκB-α promoter are required for induction of gene expression by TNFα. Nucleic Acids Res. 22:3787–3792.
   PubMedGoogle Scholar
• Jans, D. A., Xiao C.-Y., and Lam M. H. C.. 2000. Nuclear targeting signal recognition: a key control point in nuclear transport? BioEssays 22:532–544.
   PubMed Web of Science ®Google Scholar
• Kalb, A., Bluethmann H., Moore M. W., and Lesslauer W.. 1996. Tumor necrosis factor receptors (Tnfr) in mouse fibroblasts deficient in Tnfr1 or Tnfr2 are signaling competent and activate the mitogen-activated protein kinase pathway with differential kinetics. J. Biol. Chem. 271:28097–28104.
   PubMedGoogle Scholar
• Karin, M., and Ben-Neriah Y.. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621–663.
   PubMed Web of Science ®Google Scholar
• Le Bail, O., Schmidt-Ullrich R., and Israel A.. 1993. Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family. EMBO J. 12:5043–5049.
   PubMed Web of Science ®Google Scholar
• Li, Q., and Verma I.. 2002. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2:725–734.
   PubMed Web of Science ®Google Scholar
• Li, Q., Estepa G., Memet S., Israel A., and Verma I. M.. 2000. Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation. Genes Dev. 14:1729–1733.
   PubMed Web of Science ®Google Scholar
• Li, Q., Lu Q., Hwang J. Y., Buscher D., Lee K. F., Izpisua-Belmonte J. C., and Verma I. M.. 1999. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13:1322–1328.
   PubMed Web of Science ®Google Scholar
• Li, Q., Van Antwerp D., Mercurio F., Lee K. F., and Verma I. M.. 1999. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 284:321–325.
   PubMed Web of Science ®Google Scholar
• Medzhitov, R., and Janeway C., Jr. 2000. Innate immunity. N. Engl. J. Med. 343:338–344.
   PubMed Web of Science ®Google Scholar
• Mercurio, F., Zhu H., Murray B. W., Shevchenko A., Bennett B. L., Li J. W., Young D. B., Barbosa M., Mann M., Manning A., and Rao A.. 1997. IKK-1 and IKK-2: cytokine-activated IkB kinases essential for NF-kB activation. Science 278:860–866.
   PubMed Web of Science ®Google Scholar
• Regnier, C. H., Song H. Y., Gao X., Goeddel D. V., Cao Z., and Rothe M., M. 1997. Identification and characterization of an IkB kinase. Cell 90:373–383.
   PubMed Web of Science ®Google Scholar
• Schnare, M., Barton G. M., Holt A. C., Takeda K., Akira S., and Medzhitov R.. 2001. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2:947–950.
   PubMed Web of Science ®Google Scholar
• Stein, B., Baldwin A. S., Jr., Ballard B. W., Greene W. C., Angel P., and Herrlich P.. 1993. Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potential biological function. EMBO J. 12:3879–3891.
   PubMed Web of Science ®Google Scholar
• Stein, B., Cogswell P. C., Jr., and Baldwin A. S.. 1993. Functional and physical associations between NF-κB and C/EBP family members: Rel domain-b-ZIP interaction. Mol. Cell. Biol. 13:3964–3974.
   PubMed Web of Science ®Google Scholar
• Takeda, K., Takeuchi O., Tsujimura T, Itami S., Adachi O., Kawai T., Sanjo H., Yoshikawa K., Terada N., and Akira S.. 1999. Limb and skin abnormalities in mice lacking IKKα. Science 284:313–316.
   PubMed Web of Science ®Google Scholar
• Tanaka, M., Fuentes M. E., Yamaguchi K., Durnin M. H., Dalrymple S. A., Hardy K. L., and Goeddel D. V.. 1999. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity 10:421–429.
   PubMed Web of Science ®Google Scholar
• Turpin, P., Ossareh-Nazari B., and Dargemont C.. 1999. Nuclear transport and transcriptional regulation. FEBS Lett. 452:82–86.
   PubMedGoogle Scholar
• Vig, E., Green M., Liu Y., Donner D. B., Mukaida N., Goebl M. G., and Harrington M. A.. 1999. Modulation of tumor necrosis factor and interleukin-1 dependent NF-kB activity by mPLK/IRAK. J. Biol. Chem. 274:13077–13084.
   PubMedGoogle Scholar
• Vig, E., Green M., Liu Y., Kang-Yeol K., Kwon H.-J., Tian J., Goebl M., and Harrington M. A.. 2001. SIMPL is a TNF RI-mPLK/IRAK dependent NF-κB activator. J. Biol. Chem. 276:7859–7866.
   PubMedGoogle Scholar
• Woronicz, J. B., Gao Z., Cao Z., Rothe M., and Goeddel D. V.. 1997. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278:866–869.
   PubMed Web of Science ®Google Scholar
• Zandi, E., Rothwarf D. M., Delhase M., Hayakawa M., and Karin M.. 1997. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91:243–252.
   PubMed Web of Science ®Google Scholar